Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

AMA Backs House Reform Bill, Other Groups, Businesses Eye Reform Positions
The American Medical Association has backed the House bill that carries mandates on employers and individuals, a government-run health plan and reforms to Medicare and Medicaid, Politico reports.
generic viagra online
Teens Are Exposed To Tobacco Content On Social Networking Sites
When teens surf the Internet, are they exposed to tobacco content or imagery? The study, "Exposure to Tobacco on the Internet: Content Analysis of Adolescents" Internet Use," tracked the Web pages viewed by 346 teens between the ages of 14 and 17 years. During a one-month period of data collection, these adolescents viewed 1.2 million Web pages. Of those pages, 0.72 percent contained tobacco or smoking content. Pro-tobacco content was found on 1,916 pages, anti-tobacco content on 1,572 pages, and complex and/or unclear content on 5,055 pages. Most of the tobacco-related content seen by teens was found on social networking sites. MySpace in particular represented 53 percent of the pages on which tobacco content was found. Previous studies have found a link between exposure to tobacco content in traditional media and adolescent smoking. The authors caution that as more communication occurs online in social networking sites, this may also impact adolescent smoking.
News of the day
Yale Hosts Global Health Leaders From Five Countries To Inspire New Approaches To Improving Healthcare
This month, Yale University"s newly launched Global Health Leadership Institute will host "Strategic Problem Solving in Global Health," an innovative conference that will bring together health officials from five countries and members of Yale"s global health community to generate a high-level dialogue on how to approach vital health care issues facing each country. Officials from Ethiopia, Ghana, Liberia, Mexico, and Rwanda will attend the meeting, which will take place in New Haven from June 15-19.
Endocrinology

PolyMedix Receives United States Patent For Angiogenesis Inhibitor Compounds

PolyMedix, Inc. (OTCBB: PYMX), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, announced that the United States Patent and Trademark Office issued a patent assigned to PolyMedix relating to angiogenesis inhibitors. The patent, number 7,553,876, entitled "Polycationic Compounds and Uses Thereof," relates to therapeutic uses of PolyMedix compounds for inhibiting angiogenesis. Angiogenesis is a process involving the growth of new blood vessels. The abnormal growth of new blood vessels is associated with many diseases, including age-related macular degeneration (AMD), the most common form of blindness in the elderly, cancers, and inflammation. Inhibiting abnormal angiogenesis may be useful therapy for these conditions. Lucentis® and Macugen® are two products currently approved for treatment of AMD. PolyMedix"s angiogenesis inhibitors may have a mechanism of action distinct from compounds that only inhibit VEGF (vascular endothelial growth factor). "This is an exciting accomplishment for PolyMedix. This patent represents the first allowance from our applications relating to angiogenesis inhibition, and another compelling example of the efficiency and capabilities of our drug discovery approach," commented Nicholas Landekic, President and Chief Executive Officer. PolyMedix, Inc.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009